Results 281 to 290 of about 126,447 (301)
Some of the next articles are maybe not open access.
Infantile hemangioma. Part 2: Management.
Journal of American Academy of Dermatology, 2021D. Sebaratnam +3 more
semanticscholar +1 more source
Journal of the American Academy of Dermatology, 2006
Anna L, Bruckner, Ilona J, Frieden
openaire +2 more sources
Anna L, Bruckner, Ilona J, Frieden
openaire +2 more sources
Adverse Drug Reactions Following Propranolol in Infantile Hemangioma
Indian Pediatrics, 2021Vaibhav Pandey +5 more
semanticscholar +1 more source
Diagnosis and Management of Infantile Hemangiomas
Pediatric Clinics of North America, 2014Propranolol has replaced corticosteroids as preferred first-line therapy for the management of infantile hemangiomas (IH). The topical β-blocker timolol is now an alternative to oral propranolol and watchful waiting for smaller IH. Research in the last decade has provided evidence-based data about natural history, epidemiology, and syndromes associated
openaire +3 more sources
The flavonoid luteolin suppresses infantile hemangioma by targeting FZD6 in the Wnt pathway
Investigational new drugs, 2021Yujian Dai +4 more
semanticscholar +1 more source
Insights into the mechanisms of angiogenesis in infantile hemangioma.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapieShanshan Xiang +7 more
semanticscholar +1 more source
Infantile Hemangioma in the Airway
Anesthesiology, 2015Justin L. Lockman, Alan Jay Schwartz
openaire +2 more sources
Recurrence rate of infantile hemangioma after oral propranolol therapy
European Journal of Pediatrics, 2020G. Frongia +3 more
semanticscholar +1 more source